Literature DB >> 2107973

Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma.

J H Finke1, P Rayman, J Alexander, M Edinger, R R Tubbs, R Connelly, E Pontes, R Bukowski.   

Abstract

Previously we showed that IL2 expanded tumor-infiltrating lymphocytes (TILs) from renal cell carcinoma mediated non-major histocompatibility complex-restricted cytotoxicity. Phenotypic analysis showed that cultured TILs were composed mostly of T-lymphocytes with varying numbers of CD4+, CD8+, and CD56+ (Leu19+) populations. Here we compared the cytolytic activity of the two predominant TIL subsets, CD3+CD4+ and CD3+CD8+, to that of the CD56+ populations. Using magnetic beads coated with antibodies to either CD4 or CD8, CD3+CD4+, and CD3+CD8+ TILs were isolated in a highly enriched form (greater than 92%) and could be expanded for over 40 days in vitro with 1000 units/ml IL2. In a 4-h 51Cr release assay the CD4+ and CD8+ TILs showed minimal lytic activity, whereas unseparated cells exhibited significant levels of non-major histocompatibility complex-restricted cytotoxicity. The lytic activity seen in the 4-h assay with unseparated TILs appeared to be related to the presence of CD56+ populations. With one exception none of the purified CD4+ or CD8+ TILs expressed any significant levels of CD56, while the unseparated TILs contained varying numbers of CD3+CD56+ and CD3-CD56+ populations. Cell-sorting experiments verified that the CD56+ populations were responsible for most of the lytic activity in 4 h even though CD3+CD56- cells represented the predominant cell type. Although CD3+CD56- TILs were minimally lytic in 4 h, we show here that both CD3+CD4+ and CD3+CD8+ subsets displayed substantial cytotoxicity in long-term assays. In the 18-h 51Cr release assay 5 of 6 CD4+ and 2 of 3 CD8+ TILs were lytic for the autologous tumor. In two cases, restimulation with the autologous tumor induced augmented cytolytic activity of TIL subsets and in one case induced lytic activity in 4 h. The cytotoxic activity of TIL subsets was further examined using a 72-h assay in which TILs were cocultured with a confluent layer of tumor cells. The degree of cytotoxicity was quantitated by measuring the amount of crystal violet dye that was incorporated by tumor cells which remained after the incubation period. CD4+ and CD8+ TILs typically caused greater than a 50% reduction of tumor cells in 3 days and the level of reduction was increased when IL2 was added to the cultures. All the CD4+ and CD8+ subset preparations were cytotoxic in the 3-day assay even though some were not lytic for certain targets in the 18-h 51Cr release assay.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2107973

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  Effects of peritoneal macrophage autophagy on the immune function of sepsis mice.

Authors:  Da-Long Zhang; Shun-Wen Zhang; Qing Hong Cheng; Fang Wu; Jiang-Dong Wu; Jie Zhang; Jiang-Tao Dong; Hui-Yun Zhu; Shuai Zhang; Qing-Qing Wu; Wan-Jiang Zhang
Journal:  Am J Clin Exp Immunol       Date:  2017-06-15

Review 2.  Tumor-infiltrating lymphocytes: their phenotype, functions and clinical use.

Authors:  T L Whiteside; G Parmiani
Journal:  Cancer Immunol Immunother       Date:  1994-07       Impact factor: 6.968

Review 3.  Myeloid-derived suppressor cells adhere to physiologic STAT3- vs STAT5-dependent hematopoietic programming, establishing diverse tumor-mediated mechanisms of immunologic escape.

Authors:  Peter A Cohen; Jennifer S Ko; Walter J Storkus; Christopher D Spencer; Judy M Bradley; Jessica E Gorman; Dustin B McCurry; Soroya Zorro-Manrique; Anna Lucia Dominguez; Latha B Pathangey; Patricia A Rayman; Brian I Rini; Sandra J Gendler; James H Finke
Journal:  Immunol Invest       Date:  2012       Impact factor: 3.657

4.  Prognostic value of the immunomonitoring of patients with renal cell carcinoma under therapy with IL-2/IFN-alpha-2 in combination with 5-FU.

Authors:  B Göhring; D Riemann; U Rebmann; H Heynemann; J Schabel; J Langner
Journal:  Urol Res       Date:  1996

5.  Activated T-cell subsets in benign lymphoid hyperplasias and B-cell non-Hodgkin's lymphomas.

Authors:  J I Diaz; M G Edinger; M H Stoler; R R Tubbs
Journal:  Am J Pathol       Date:  1991-09       Impact factor: 4.307

6.  Enhancement of the lytic activity of cloned human CD8 tumour-infiltrating lymphocytes by bispecific monoclonal antibodies.

Authors:  A Gorter; K M Krüse; P I Schrier; G J Fleuren; R J van de Griend
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

7.  Characterization of fresh (uncultured) tumour-infiltrating lymphocytes (TIL) and TIL-derived T cell lines from patients with renal cell carcinoma.

Authors:  D Mitropoulos; S Kooi; J Rodriguez-Villanueva; C D Platsoucas
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

8.  Characterization and augmentation of CD4+ cytotoxic T cell lines against melanoma.

Authors:  T Morisaki; D L Morton; A Uchiyama; D Yuzuki; A Barth; D S Hoon
Journal:  Cancer Immunol Immunother       Date:  1994-09       Impact factor: 6.968

9.  Cell surface expression and serum levels of intercellular adhesion molecule-1 in renal cell carcinoma.

Authors:  R Heicappell; J Podlinski; H Buszello; R Ackermann
Journal:  Urol Res       Date:  1994

10.  T lymphocytes that infiltrate tumors and atherosclerotic plaques produce heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor: a potential pathologic role.

Authors:  G E Peoples; S Blotnick; K Takahashi; M R Freeman; M Klagsbrun; T J Eberlein
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.